Irinotecan in Combined-Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer
January 1st 2001The management of non-small-cell lung cancer is undergoing rapid evolution. Although the advent of combined-modality therapy has led to improved survival, most patients eventually succumb to the disease. The arrival of a